As the House Energy and Commerce Committee prepares to consider a legislative provision (H.R. 3561) that would reduce payments for drug administration services furnished in off-campus provider-based departments, the AHA and other national hospital groups reiterated to committee leaders their opposition to the proposal and to site-neutral policies in general, which fail to account for the fundamental differences between hospital outpatient departments (HOPDs) and other ambulatory care sites. 

“It is important to note that HOPDs treat patients who are sicker and have more chronic conditions than those treated in physician offices or ambulatory surgical centers, as they are better equipped to handle complications and emergencies,” the letter notes. The committee is scheduled to consider H.R. 3561 tomorrow.

AHA also released a fact sheet highlighting three site-neutral proposals being considered by the committee and their estimated impact on Medicare reimbursement to hospitals and health systems; the estimates should not be combined because the legislative proposals contain some overlap. 

Headline
The AHA and dozens of other organizations April 14 sent a letter of support to Reps. Suzan DelBene, D-Wash., and Mike Kelly, R-Pa., for their introduction…
Headline
The Medicare Payment Advisory Commission met April 9 and 10 to discuss several topics, including the relationship between Medicare Advantage enrollment and…
Headline
The Centers for Medicare & Medicaid Services issued an updated registration link for its webinar April 16 at 3 p.m. ET on Medicare Clinical…
Perspective
Public
Few patient populations are more vulnerable to the shifting winds around health care today than Medicare beneficiaries who need specialized, high-acuity and…
Headline
The Centers for Medicare & Medicaid Services April 6 released the Medicare Advantage and Part D Rate Announcement for calendar year 2027. The rate…
Headline
The Centers for Medicare & Medicaid Services April 2 released a final rule on policy and technical changes to Medicare Advantage, the Medicare Prescription…